(RTTNews) - InnoCare Pharma Ltd. (INCPF, 9969.HK) announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved its Investigational New Drug (IND) applicatio…
(RTTNews) - Avalyn Pharma Inc. (AVLN), a clinical-stage biopharmaceutical company focused on inhaled therapies for respiratory diseases, presented new data at the European Respiratory Society (ERS) International Congres…
(RTTNews) - Barnes & Noble Education, Inc. (BNED), an operator of college bookstores, announced a narrower net loss for the first quarter of fiscal 2027, helped by increased revenue.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
It's hard to remember that Amazon (NASDAQ: AMZN) started as an online bookseller in 1994. Thanks to co-founder and then-CEO Jeff Bezos' vision, it quickly grew to sell virtually everything imaginable online. Today, it h…
iShares U.S. Pharmaceuticals ETF targets a specific subsector with 56 holdings, while iShares U.S. Healthcare ETF spans the broader industry with 100 holdings.
Vistra's (NYSE: VST) stock closed at a record high of $217.02 per share on Sept. 22, 2025. That marked a whopping 556% gain over its previous two years, and was largely driven by the explosive growth of the power-hungry…
The NASDAQ 100 Pre-Market Indicator is up 32.06 to 29,576.22. The total Pre-Market volume is currently 103,790,161 shares traded.The following are the most active stocks for the pre-market session: Nokia Corporation (NO…
After facing valuation pressures in July, Micron (NASDAQ: MU) stock came bounding back in August's trading. The company's share price rose 16.5% in the month, according to data from S&P Global Market Intelligence. Meanw…
(RTTNews) - HORNBACH Holding AG & Co. KGaA (HBH.DE) reported that preliminary net sales for the second-quarter increased by 7.3% to 1.814 billion euros from last year, driven by robust customer demand and a positive cal…
We use cookies to improve your experience and analyse site traffic. By continuing to browse, you agree to our use of cookies.